About: Advances in targeted therapies IX

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Advances in targeted therapies IX Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/bmj/periodical/ard/2007/volume_66
Title	Advances in targeted therapies IX
has manifestation of work	http://hub.abes.fr/bmj/periodical/ard/2007/volume_66/issue_suppl3/m/print http://hub.abes.fr/bmj/periodical/ard/2007/volume_66/issue_suppl3/m/web
Date Copyrighted	2007
Rights	2007 BMJ Publishing Group and European League Against Rheumatism
issue	suppl 3
is Is Part Of of	Thoughts on health economics in rheumatoid arthritis Regulatory T cells and toll-like receptors: regulating the regulators Systemic lupus erythematosus: new molecular targets Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility Interplay between pathogenic Th17 and regulatory T cells Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 Disease activity assessment in SLE: do we have the right instruments? Advances in targeted therapies IX Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis New therapies for sepsis: focus on the interleukin (IL)12 family member IL27 Amplifying elements of arthritis and joint destruction Interpreting measurements of physical function in clinical trials Joint remodelling in inflammatory disease Schnurri-3 is an essential regulator of osteoblast function and adult bone mass Update on toll-like receptor-directed therapies for human disease Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? α-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata